β-catenin turnover is regulated by Nek10-mediated tyrosine phosphorylation in A549 lung adenocarcinoma cells

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Signaling

Background:

• Beta-catenin is a key protein in cell adhesion and signaling pathways.
• Dysregulation of beta-catenin is implicated in various human cancers, including lung adenocarcinoma.
• Cellular beta-catenin levels are tightly controlled by complex regulatory networks.

Purpose of the Study:

• To investigate the role of Nek10 tyrosine kinase in regulating beta-catenin.
• To elucidate the mechanism by which Nek10 influences beta-catenin stability and turnover.
• To assess the impact of Nek10 deficiency on lung adenocarcinoma progression and tumorigenicity.

Main Methods:

• Utilized lung adenocarcinoma cell lines with and without Nek10.
• Assessed beta-catenin stabilization and degradation pathways.
• Performed in vitro tumor sphere and soft agar assays.
• Evaluated tumor colonization in vivo using mouse models.
• Investigated the interaction of Nek10 with the Axin complex and its phosphorylation of beta-catenin.

Main Results:

• Deletion of Nek10 led to significant stabilization of beta-catenin in lung adenocarcinoma cells.
• Nek10-deficient cells showed reduced tumor sphere formation, soft agar growth, and lung colonization.
• Nek10 directly associates with the Axin complex and phosphorylates beta-catenin at Tyr30.
• This phosphorylation is essential for subsequent GSK3-mediated phosphorylation and beta-catenin turnover.

Conclusions:

• Nek10 acts as a novel regulator of beta-catenin turnover through tyrosine phosphorylation.
• Nek10's function in phosphorylating beta-catenin at Tyr30 is critical for its degradation.
• Loss of Nek10 promotes lung adenocarcinoma progression by stabilizing beta-catenin, highlighting Nek10 as a potential therapeutic target.